Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Equity Average (2022 - 2025)

Prokidney (PROK) has disclosed Equity Average for 4 consecutive years, with -$1.0 billion as the latest value for Q4 2025.

  • Quarterly Equity Average fell 2.26% to -$1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 billion through Dec 2025, down 2.26% year-over-year, with the annual reading at -$1.0 billion for FY2025, 4.39% up from the prior year.
  • Equity Average for Q4 2025 was -$1.0 billion at Prokidney, roughly flat from -$1.0 billion in the prior quarter.
  • The five-year high for Equity Average was $13.4 million in Q2 2022, with the low at -$1.5 billion in Q2 2023.
  • Average Equity Average over 4 years is -$990.3 million, with a median of -$1.0 billion recorded in 2025.
  • The sharpest move saw Equity Average plummeted 11048.79% in 2023, then increased 29.25% in 2024.
  • Over 4 years, Equity Average stood at -$1.1 billion in 2022, then dropped by 0.14% to -$1.1 billion in 2023, then increased by 10.08% to -$987.3 million in 2024, then dropped by 2.26% to -$1.0 billion in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at -$1.0 billion, -$1.0 billion, and -$1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.